OCT 08, 2020 5:30 AM PDT

Oral cancer pain levels indicate metastasis

A new study from NYU College of Dentistry researchers provides insight as to why patients with metastatic oral cancer experience greater pain than patients with oral cancer that has not spread to other parts of the body. The study is published in the journal Scientific Reports.

Study author Brian L. Schmidt, DDS, MD, PhD, is director of the NYU Oral Cancer Center. He has dedicated his career to understanding oral cancer. "I have been investigating the underlying cause of oral cancer pain for two decades. This is the first time that we have demonstrated a correlation between a patient's pain and the clinical behavior of the cancer," says Schmidt.

Oral cancer can cause patients severe pain when talking and eating. Now genetic and cellular clues suggest that oral cancer is more likely to metastasize in patients experiencing high levels of pain. When oral cancer spreads to the lymph nodes, survival rates drop by half. Yet, detecting this spread through the available imaging methods is difficult. If pain levels could be used as indicators of spread, say the researchers, it may be possible to detect metastasis earlier on.

"Clinicians and researchers are keen to define a biomarker that accurately predicts metastasis," said lead author Aditi Bhattacharya, PhD, an assistant professor in the Department of Oral and Maxillofacial Surgery at NYU College of Dentistry and an investigator at NYU Bluestone Center for Clinical Research. "Given that patients with metastatic oral cancer experience more pain, we thought that a patient's level of pain might help predict metastasis. A surgeon could then use this knowledge to only remove lymph nodes in patients with cancers that are most likely to metastasize."

As of now, surgeons often preemptively remove lymph nodes in an invasive surgery called prophylactic neck dissection in order to stave off metastasis. However, estimates suggest that up to 70% are unnecessary.

Photo: Pixabay

In conducting their analysis, the researchers found differences in gene expression between metastatic cancers from patients with high levels of pain versus non-metastatic cancers from patients not experiencing pain. The team found 40 genes that were more highly expressed in painful metastatic cancers.  

The researchers say these genes could act as biomarkers for oral cancer metastasis and could assist providers in making difficult decisions about surgery procedures. "While we need to undertake a follow-up study, our current data reveals that a patient's pain intensity score works as well as the current method--the depth of invasion, or how deeply a tumor has invaded nearby tissue--as an index to predict metastasis," said Bhattacharya.

Sources: Scientific Reports, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
OCT 05, 2020
Cancer
Fighting mitochondrial terminal exhaustion
OCT 05, 2020
Fighting mitochondrial terminal exhaustion
New findings reported in Nature Immunology highlight how the tumor microenvironment attacks the mitochondria of T l ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
OCT 27, 2020
Cancer
Increased muscle mass improves outcomes for colorectal cancer surgery
OCT 27, 2020
Increased muscle mass improves outcomes for colorectal cancer surgery
New research published in JAMA Surgery reports a new way to prepare for surgery: sit-ups. According to the findings ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
NOV 15, 2020
Genetics & Genomics
Novel Cancer-Driving Genes are Discovered
NOV 15, 2020
Novel Cancer-Driving Genes are Discovered
Cells have to be able to divide so new ones can replenish cells that get worn out, dysfunctional, or that accumulate dam ...
Loading Comments...